Wondermed pulls $4,600K out of a hole to ply you with ketamine
For those of us who’ve been a little bit wobbly on the mental health front over the past couple of years, there are a bunch of options starting...
Read moreCategory: depression
Depressed? This algorithm can tell from the tone of your voice
Mental health issues have come into a clearer focus amid the pandemic. Depression became endemic, but it still too often goes undetected. Even when...
Read more
6 questions investors should ask when evaluating psychedelic biotech companies
We believe in a future where psychedelic therapy will be as common as going to the dentist, but the path won’t be easy.
Read more
InFlow, a science-based app for ADHD, raises $2.3M Seed led by Hoxton Ventures
Attention deficit hyperactivity disorder (ADHD) symptoms can include anxiety, chronic boredom, impulsiveness, trouble concentrating, controlling...
Read more
How Cerebral and Alto Neuroscience embarked on an at-home clinical trial for depression
Before the pandemic forced remote work, school and research to the forefront, decentralized clinical trials were probably on the horizon. Now,...
Read more
A look inside Offline Ventures, co-founded by Brit and Dave Morin and backed in part by Apple
Last year, entrepreneurs, investors and married couple Dave and Brit Morin teamed up with James Higa, who was a senior director at Apple for nearly a...
Read more
Journey Clinical raises $3M to allow psychotherapists to prescribe psychedelics
Psychedelics companies are all the rage right now. Compass Pathways is working with the magic mushroom compound psilocybin to treat depression....
Read more